PP
ABMD

Paloma Partners’s Abiomed Inc ABMD Stock Holding History

Paloma Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,500
Closed -$978K – 2611
2019
Q3 		$978K Buy
+5,500
New +$1.19M 0.02% 754
2019
Q2 		– Sell
-800
Closed -$228K – 2295
2019
Q1 		$228K Sell
800
-200
-20% -$66.5K 0.01% 1449
2018
Q4 		$325K Buy
+1,000
New +$347K 0.01% 838

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paloma Partners's ABMD Position: Q3 2021 in Review

Paloma Partners sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 2,770 shares — an estimated $864K sold.

Paloma Partners first reported a position in ABMD in Q3 2015 and held it in 15 quarters. The position peaked at $10.2M in Q2 2016. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Paloma Partners reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • Paloma Partners sold 2,770 Abiomed Inc shares in Q3 2021, an estimated $864K.
  • Paloma Partners first reported a position in Abiomed Inc in Q3 2015 and held it in 15 quarters.
  • Paloma Partners's Abiomed Inc position peaked at $10.2M in Q2 2016.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.